These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 7422532)

  • 21. [A new antianginal preparation: isosorbide-5-mononitrate].
    Martsevich SIu; Metelitsa VI; Slastnikova ID; Simkhaev LS; Egorov LV; Blagodatskikh SV
    Kardiologiia; 1990 Oct; 30(10):44-6. PubMed ID: 2290270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of dinitrate isosorbide retard forms in ischemic heart disease patients with stable effort angina].
    Lupanov VP; Alekseeva IA; Vasil'eva NN; Komar OA; Romasiuk SS; Naumov VG
    Ter Arkh; 2000; 72(9):33-6. PubMed ID: 11076413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of the effectiveness of new delayed-action isosorbide dinitrate preparations in patients with exertion-induced stenocardia].
    Martsevich SIu; Metelitsa VI
    Klin Med (Mosk); 1986 Jun; 64(6):37-40. PubMed ID: 3747434
    [No Abstract]   [Full Text] [Related]  

  • 24. [Evaluation of antianginal efficacy of long-term therapy with low dose isosorbide dinitrate in patients with stable angina pectoris].
    Kośmicki M; Sadowski Z
    Przegl Lek; 2000; 57(9):455-8. PubMed ID: 11199864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation by means of atrial pacing of the hemodynamic and clinical effects of a delayed-action isosorbide dinitrate preparation in patients with angina pectoris].
    Ray M; Salerno JA; Chimienti M; Storti D; Fici F; Tavazzi L; Bobba P
    Minerva Cardioangiol; 1977 Jan; 23(1):53-62. PubMed ID: 840399
    [No Abstract]   [Full Text] [Related]  

  • 26. [Influence of combination therapy (isosorbide dinitrate and molsidomine) on the incidence of angina pectoris in patients with coronary heart disease].
    Ciopor M; Fischer A; Turina J; Hess OM
    Praxis (Bern 1994); 1997 Nov; 86(47):1849-53. PubMed ID: 9480502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single administration of atenolol does not influence the kinetics of orally given isosorbide dinitrate.
    Bogaert MG; Rosseel MT; Bruyneel K
    Int J Clin Pharmacol Res; 1983; 3(6):491-3. PubMed ID: 6678835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Assay of plasma isosorbide dinitrate and its metabolites after oral administration of immediate and delayed-action forms].
    Audry E; Dallet P; Dubost JP; Langlois MH; Ernouf D; Narcisse G
    Ann Pharm Fr; 1989; 47(4):235-41. PubMed ID: 2637644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Disparate efficacy of isosorbide dinitrate, in sustained-release form, during acute and chronic administration (author's transl)].
    Blasini R; Brügmann U; Mannes A; Froer KL; Hall D; Rudolph W
    Herz; 1980 Oct; 5(5):298-305. PubMed ID: 7450664
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical pharmacokinetics of nitrates.
    Bogaert MG
    Cardiovasc Drugs Ther; 1994 Oct; 8(5):693-9. PubMed ID: 7873466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous determination of isosorbide dinitrate and its mononitrates in human plasma by capillary column GLC.
    Rosseel MT; Bogaert MG
    J Pharm Sci; 1979 May; 68(5):659-60. PubMed ID: 430513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fate of orally given isosorbide dinitrate in man: factors of variability.
    Bogaert MG; Rosseel MT
    Z Kardiol; 1983; 72 Suppl 3():11-3. PubMed ID: 6141676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative pharmacokinetics of isosorbide nitrates after repeated doses of sustained release isosorbide dinitrate.
    Laufen H; Leitold M; Wildfeuer A
    Arzneimittelforschung; 1988 Sep; 38(9):1336-41. PubMed ID: 3223973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative study of isosorbide dinitrates and mononitrates in patients with ischemic heart disease and stable angina pectoris caused by stenosing coronary atherosclerosis].
    Lupanov VP; Alekseeva IA; Vasil'eva NN; Chotchaev KhKh; Naumov VG
    Klin Med (Mosk); 2000; 78(9):52-5. PubMed ID: 11051743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is isosorbide mononitrate better than the dinitrate?
    Drug Ther Bull; 1984 Jan; 22(2):7-8. PubMed ID: 6363029
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparison of the efficacy and duration of action of 2 isosorbide dinitrate preparations].
    Magelli C; Marzocchi A; Ferretti RM; Bassein L; Magnani B
    Cardiologia; 1982; 27(6):609-14. PubMed ID: 6892440
    [No Abstract]   [Full Text] [Related]  

  • 37. Concentrations of the vasodilator isosorbide dinitrate and its metabolites in the blood of human subjects.
    Chasseaud LF; Down WH; Grundy RK
    Eur J Clin Pharmacol; 1975 Apr; 8(3-4):157-60. PubMed ID: 1233213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mononitrates as monotherapy in the prophylactic treatment of angina pectoris.
    Rehnqvist N; Nyberg G; Carlens P; Lindström E; Lundman T; Nordlander R; Ulvenstam G; Aberg A; Aström H
    Drugs; 1987; 33 Suppl 4():100-3. PubMed ID: 3622313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative study of the bioavailability and pharmacokinetics of isosorbide dinitrate formulations in retard form and in standard preparations by determination of isosorbide-5-mononitrate].
    Lutz VD; Gielsdorf W; Rasper J; Jaeger H; Loew D
    Arzneimittelforschung; 1985; 35(4):730-4. PubMed ID: 4015739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparison of the anti-angina effect and effect duration of isosorbide dinitrate, isosorbide-2-mononitrate (IS-2-MN) and isosorbide-5-mononitrate (IS-5-MN)].
    Reifart N; Reifart F; Kaltenbach M; Bussmann WD
    Med Welt; 1981 Apr; 32(14A):524-6. PubMed ID: 7242313
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.